Compare SMWB & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMWB | INMD |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | Israel | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 778.8M | 805.0M |
| IPO Year | 2021 | 2018 |
| Metric | SMWB | INMD |
|---|---|---|
| Price | $9.00 | $14.25 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 5 |
| Target Price | $10.83 | ★ $16.17 |
| AVG Volume (30 Days) | ★ 485.5K | 413.7K |
| Earning Date | 11-10-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.98 | N/A |
| Revenue Next Year | $11.01 | $2.30 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.22 | $12.72 |
| 52 Week High | $9.50 | $16.67 |
| Indicator | SMWB | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 64.07 | 44.45 |
| Support Level | $7.83 | $14.19 |
| Resistance Level | $9.50 | $15.21 |
| Average True Range (ATR) | 0.42 | 0.16 |
| MACD | 0.11 | 0.02 |
| Stochastic Oscillator | 87.56 | 68.62 |
Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.